Phase 2 KRAS Mutation-Related Tumors Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Colorectal, CancerColorectal CarcinomaNon-small Cell Lung Cancer+29 more

Institut de Recherches Internationales Servier554 enrolled27 locationsNCT05786924

Recruiting

Phase 1Phase 2

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Triple-Negative Breast CancerOvarian CancerCervical Cancer+3 more

University of California, Irvine67 enrolled1 locationNCT07064018